The validations confirm the completion of the applications and commence the scientific review process
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Connecting new production and consumption areas of chilled food by low-carbon transportation services
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Subscribe To Our Newsletter & Stay Updated
